| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | High mobility group protein B1|High mobility group protein 1|HMG-1|HMGB1|HMG1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse Hmgb1 (High mobility group protein B1) is a molecular target commonly studied in epigenetics, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of Hmgb1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Hmgb1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Hmgb1 (High mobility group protein B1) may also be referenced as High mobility group protein B1, High mobility group protein 1, and HMG-1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Hmgb1 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in epigenetics, signal transduction, and neuroscience research.
- Interpreting shifts in Hmgb1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Hmgb1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with epigenetics, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Brain ischemia causes systemic Notch1 activity in endothelial cells to drive atherosclerosis
IF: 25.5 Journal: Immunity Author: Department of Neurology, Tianjin Neurological Institute, Tianjin Institute of Immunology, State Key Laboratory of Experimental Hematology, International Joint Laboratory of Ocular Diseases, Ministry of Education, Haihe Laboratory of Cell Ecosystem, Labora Cited Date: 2024-08-02
A Peptide Nanoregulator Enriched at the Endoplasmic Reticulum for Boosting Fractionated Radiotherapy‐Mediated Antitumor Immune Response
IF: 19 Journal: Advanced Functional Materials Author: State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Tianjin Institutes of Health Science, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Pekin Cited Date: 2025-10-17
E-prostanoid 3 receptor deficiency on myeloid cells protects against ischemic acute kidney injury via breaking the auto-amplification loop of necroinflammation
IF: 18.998 Journal: Kidney International Author: Cardiovascular Research Center, Shantou University Medical College, Shantou, China Cited Date: 2022-09-23
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
IF: 17.69 Journal: Nature Communications Author: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore Cited Date: 2023-06-02
Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy
IF: 17.1 Journal: ACS Nano Author: School of Medicine, Chongqing University, Chongqing 400044, China. Cited Date: 2024-05-31
Spatial Regulation of Cancer-Associated Fibroblasts and Tumor Cells via pH-Responsive Bispecific Delivery for Enhanced Chemo-Immunotherapy Synergy
IF: 15.8 Journal: ACS Nano Author: National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China. Cited Date: 2025-04-25
FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation
IF: 13.3 Journal: Autophagy Author: Department of Neurology, Mental and Neurological Disease Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China Cited Date: 2023-10-13
A cuproptosis-based nanomedicine suppresses triple negative breast cancers by regulating tumor microenvironment and eliminating cancer stem cells
IF: 12.8 Journal: Biomaterials Author: Department of Nanomedicine and Biopharmaceuticals, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, P. R. China Cited Date: 2024-08-23
Manganese ion chelated nanoassemblies synergizing metalloimmunotherapy-chemodynamic for potentiating glioblastoma treatment
IF: 12.6 Journal: Journal of Nanobiotechnology Author: Department of Biomedical Engineering, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, China. Cited Date: 2025-12-26
Tumor microenvironment–activated Zn//MnO battery for sustained and local electrochemical immunotherapy
IF: 11.7 Journal: Science Advances Author: State Key Laboratory of Integrated Optoelectronics, JLU Region, College of Electronic Science and Engineering, Jilin University, Changchun 130012, China. Cited Date: 2025-06-06